Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cellular uptake and intracellular trafficking of oligonucleotides
R. L. Juliano, Kyle Carver
Advanced Drug Delivery Reviews (2015) Vol. 87, pp. 35-45
Open Access | Times Cited: 123

Showing 1-25 of 123 citing articles:

Non-coding RNAs as drug targets
Masayuki Matsui, David R. Corey
Nature Reviews Drug Discovery (2016) Vol. 16, Iss. 3, pp. 167-179
Open Access | Times Cited: 932
The delivery of therapeutic oligonucleotides
Rudolph L. Juliano
Nucleic Acids Research (2016) Vol. 44, Iss. 14, pp. 6518-6548
Open Access | Times Cited: 733
RNA-Targeted Therapeutics
Stanley T. Crooke, Joseph L. Witztum, C. Frank Bennett, et al.
Cell Metabolism (2018) Vol. 27, Iss. 4, pp. 714-739
Open Access | Times Cited: 681
Antisense oligonucleotides: the next frontier for treatment of neurological disorders
Carlo Rinaldi, Matthew J. A. Wood
Nature Reviews Neurology (2017) Vol. 14, Iss. 1, pp. 9-21
Open Access | Times Cited: 653
Cellular uptake and trafficking of antisense oligonucleotides
Stanley T. Crooke, Shiyu Wang, Timothy A. Vickers, et al.
Nature Biotechnology (2017) Vol. 35, Iss. 3, pp. 230-237
Closed Access | Times Cited: 490
Therapeutic Antisense Oligonucleotides Are Coming of Age
C. Frank Bennett
Annual Review of Medicine (2019) Vol. 70, Iss. 1, pp. 307-321
Open Access | Times Cited: 468
Chemistry, structure and function of approved oligonucleotide therapeutics
Martin Egli, Muthiah Manoharan
Nucleic Acids Research (2023) Vol. 51, Iss. 6, pp. 2529-2573
Open Access | Times Cited: 398
Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases
Meenu Mehta, Deeksha, Devesh Tewari, et al.
Chemico-Biological Interactions (2019) Vol. 308, pp. 206-215
Open Access | Times Cited: 388
Molecular Mechanisms of Antisense Oligonucleotides
Stanley T. Crooke
Nucleic Acid Therapeutics (2017) Vol. 27, Iss. 2, pp. 70-77
Open Access | Times Cited: 318
Oligonucleotide Therapies: The Past and the Present
Karin E. Lundin, Olof Gissberg, Smith Rjh
Human Gene Therapy (2015) Vol. 26, Iss. 8, pp. 475-485
Open Access | Times Cited: 249
Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery
Byungji Kim, Ji‐Ho Park, Michael J. Sailor
Advanced Materials (2019) Vol. 31, Iss. 49
Open Access | Times Cited: 243
RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus
Xue‐hai Liang, Hong Sun, Joshua G Nichols, et al.
Molecular Therapy (2017) Vol. 25, Iss. 9, pp. 2075-2092
Open Access | Times Cited: 226
Chitosan Nanoparticles at the Biological Interface: Implications for Drug Delivery
Noorjahan Aibani, Raj Rai, Parth Patel, et al.
Pharmaceutics (2021) Vol. 13, Iss. 10, pp. 1686-1686
Open Access | Times Cited: 201
Precision-Guided Missile-Like DNA Nanostructure Containing Warhead and Guidance Control for Aptamer-Based Targeted Drug Delivery into Cancer Cells in Vitro and in Vivo
Changhe Ouyang, Songbai Zhang, Chang Xue, et al.
Journal of the American Chemical Society (2020) Vol. 142, Iss. 3, pp. 1265-1277
Closed Access | Times Cited: 174
Recent Advances in Oligonucleotide Therapeutics in Oncology
Haoyu Xiong, Rakesh N. Veedu, Sarah D. Diermeier
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3295-3295
Open Access | Times Cited: 149
Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles
Jeremy Bost, Hanna M. G. Barriga, Margaret N. Holme, et al.
ACS Nano (2021) Vol. 15, Iss. 9, pp. 13993-14021
Open Access | Times Cited: 128
The uptake of metal–organic frameworks: a journey into the cell
Emily Linnane, Salame Haddad, Francesca Melle, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 14, pp. 6065-6086
Open Access | Times Cited: 127
A Lysosome‐Activated Tetrahedral Nanobox for Encapsulated siRNA Delivery
Yang Gao, Xingyu Chen, Taoran Tian, et al.
Advanced Materials (2022) Vol. 34, Iss. 46
Closed Access | Times Cited: 124
Challenges in carrier‐mediated intracellular delivery: moving beyond endosomal barriers
Martin P. Stewart, Anna St Lorenz, James E. Dahlman, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2015) Vol. 8, Iss. 3, pp. 465-478
Closed Access | Times Cited: 130
Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection
Pooja Tiwari, Daryll Vanover, Kevin E. Lindsay, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 116
Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Don’t
R. L. Juliano
Nucleic Acid Therapeutics (2018) Vol. 28, Iss. 3, pp. 166-177
Open Access | Times Cited: 109
The Interaction of Phosphorothioate-Containing RNA Targeted Drugs with Proteins Is a Critical Determinant of the Therapeutic Effects of These Agents
Stanley T. Crooke, Punit P. Seth, Timothy A. Vickers, et al.
Journal of the American Chemical Society (2020) Vol. 142, Iss. 35, pp. 14754-14771
Closed Access | Times Cited: 103
Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease
Valentina Sardone, Haiyan Zhou, Francesco Muntoni, et al.
Molecules (2017) Vol. 22, Iss. 4, pp. 563-563
Open Access | Times Cited: 94
Endosomal Escape and Cytosolic Penetration of Macromolecules Mediated by Synthetic Delivery Agents
Dakota J. Brock, Helena M. Kondow-McConaghy, Elizabeth C. Hager, et al.
Bioconjugate Chemistry (2018) Vol. 30, Iss. 2, pp. 293-304
Open Access | Times Cited: 94
LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma
Yan Xu, Yuan Li, Jiankang Jin, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 78
Page 1 - Next Page

Scroll to top